
GA22329
Hepcidin-22 (human)
Also known as (2S,3R)-2-[[(2S)-6-amino-2-[[(1R,4R,7S,10S,13S,16S,19R,25S,28R,31R,36R,39S,42S,45R,55R)-16-(4-aminobutyl)-45-[[(2S,3S)-2-[[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-39-benzyl-42-[(2S)-butan-2-yl]-10-(3-carbamimidamidopropyl)-13-(hydroxymethyl)-7-(1H-imidazol-5-ylmethyl)-25-(2-methylsulfanylethyl)-2,5,8,11,14,17,20,23,26,29,38,41,44,51,54,61-hexadecaoxo-33,34,47,48,57,58,63,64-octathia-3,6,9,12,15,18,21,24,27,30,37,40,43,50,53,60-hexadecazatetracyclo[26.21.10.44,19.236,55]pentahexacontane-31-carbonyl]amino]hexanoyl]amino]-3-hydroxybutanoic acid
An inactive degradation product of hepcidin-25 found in human urine
- CAS number
- 342790-22-1
- Molecular weight
- 2436.06
- Formula
- C99H151N29O25S9
- Solubility
- Soluble in DMSO
- InChIKey
- JUTMFNVVFBPLHR-BDBOULOUSA-N
- Catalogue number
- GA22329
- Brand
- GLPBIO
Computed properties PubChem CID 131852663 · XLogP -6.1 · TPSA 1080 Ų · H-bond donors 30
- XLogP
- -6.1
- TPSA
- 1080 Ų
- H-bond donors
- 30
- H-bond acceptors
- 39
- Rotatable bonds
- 38
- Heavy atoms
- 162
SMILES CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H]3CSSC[C@@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CC=CC=C5)N)C(=O)N[C@H]6CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC6=O)CC7=CN=CN7)CCCNC(=N)N)CO)CCCCN)NC2=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CC8=CC=CC=C8
Computed descriptors from PubChem (CID 131852663), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il